Related by context. All words. (Click for frequent words.) 69 analyst Geoffrey Meacham 68 Molowa 67 Eric Ende 67 analyst Maged Shenouda 66 analyst Ashwin Shirvaikar 66 analyst Cory Kasimov 66 analyst Yaron Werber 65 Akhtar Samad 65 analyst Randall Stanicky 64 Mark Schoenebaum 64 analyst Jim Birchenough 64 Dr. Jim Birchenough 63 analyst Jim Reddoch 63 Yaron Werber 63 analyst Julian Easthope 63 Steven Burakoff 62 analyst Hari Sambasivam 62 Carla Antunes da Silva 62 analyst George Grofik 62 George Grofik 62 analyst Lawrence Keusch 62 Jami Rubin 61 Carl Seiden 61 analyst Elizabeth Osur 60 Chris Shibutani 60 Matthew Heimermann 60 Morgan Stanely 60 analyst Andrew Goodsall 60 Gets Downgraded 60 analyst Gurinder Kalra 60 analyst Jeffrey Zekauskas 60 analyst Mark Schoenebaum 60 analyst Annabel Samimy 60 Steven Harr 60 William Tanona 60 analyst Edmo Chagas 59 Joshua Raskin 59 Reiterates Hold 59 analyst Bruce Nudell 59 Resumes Coverage 59 Jim Birchenough 59 Claudia Shank Hueston 59 Jason Kantor 59 Spin Off Discover 59 analyst Reto Huenerwadel 59 Stelios Papadopoulos 59 analyst Lori Appelbaum 59 Anthony Bucalo 59 analyst Hussein Allidina 59 John DiFucci 59 analyst Ken Trbovich 59 Susan Katzke 59 analyst Sapna Srivastava 59 Reiterates Neutral Rating 59 Geoffrey Meacham 59 analyst Jonathan Aschoff 58 Gbola Amusa 58 Annabel Samimy 58 economist Ted Wieseman 58 Smith Barney MSSB 58 Deane Dray 58 Atsushi Seki 58 Sterling Auty 58 analyst Amit Bhalla 58 analyst Robert Koort 58 Ryland Presentation 58 analyst Rebecca Runkle 58 analyst Glenn Novarro 58 analyst Julio Quinteros 58 PJ Juvekar 58 analyst Alexandra Hauber 58 Charles Minervino 58 Analysts Initiate Coverage 58 analyst Aldo Mazzaferro 57 Geoff Meacham 57 Alexandra Hauber 57 Roopesh Patel 57 Jason Kolbert 57 Manus Costello 57 Dr. Yaron Werber 57 Ross Muken 57 Steven Alexopoulos 57 Timothy Arcuri 57 please visit www.lazard.com 57 Rating Maintained 57 analyst Mark Edelstone 57 Suresh Mahadevan 57 strategist Adrian Mowat 57 Jerry Doctrow 57 analyst Michael Exstein 57 Tellabs Presentation 57 Randall Stanicky 57 analyst Uche Orji 57 Craig Siegenthaler 57 Reiterates Hold Rating 57 analyst Gbola Amusa 57 Geoff Ruddell 57 analyst Alex Gauna 57 analyst Onno Rutten 57 Joel Sendek 57 analyst Vivek Arya 57 Joe Pantginis 57 Claude Zehnder 57 Assumes Coverage 57 economist Tushar Poddar 57 Cantor Fitzgerald reiterates 57 analyst Jeffrey Kvaal 57 economist George Tharenou 57 Lowers Estimates 57 analyst Nigel Dally 57 Enoch Fung 57 economist Joachim Fels 57 strategist Edel Tully 57 Analysts Downgrade 57 David Bleustein 57 Andrew Kligerman 56 analyst Mark Wienkes 56 Ricky Goldwasser 56 analyst Amit Daryanani 56 analyst Jon Bergtheil 56 Donald Fandetti 56 Julian Easthope 56 analyst Deane Dray 56 Bruce Harting 56 Douglas Anmuth 56 analyst Gregory Badishkanian 56 Barbara Yastine 56 RESEARCH ALERT BofA 56 Matthew Borsch 56 analyst Chad Friess 56 analyst Tony Lesiak 56 Douglas Sipkin 56 Brock Vandervliet 56 analyst Timna Tanners 56 Kash Rangan 56 analyst Omotayo Okusanya 56 Minggao Shen 56 AGā 56 Tushar Poddar economist 56 Thomas V. Cholnoky 56 strategist Teun Draaisma 56 ThinkEquity upgraded 56 Jason Gurda 56 Asset Management GSAM 56 analyst Vicky Binns 56 analyst Tal Liani 56 RBC Capital Mkts Reiterate 56 analyst Eileen Furukawa 56 analyst Romit Shah 56 Reiterates Outperform 56 Michael Leuchten 56 Andreas Willi 56 analyst Joshua Shanker 56 Piero Ghezzi 56 Paul Mansky 56 Kin Ho 56 Ian Somaiya 56 analyst Kian Abouhossein 56 Joseph Pantginis 56 Leerink Swan 55 Reiterate Buy rating 55 analyst Shinichi Ina 55 analyst William Pecoriello 55 Farooq Hanif 55 Nikos Theodosopoulos 55 Eyetech Pharmaceuticals 55 Holger Blum 55 Simona Jankowski 55 JSB Partners 55 Technology XLK Bearish 55 David Hochstim 55 Jeremy Sussman 55 Kalpesh Kapadia 55 Frederick Searby 55 analyst Dara Mohsenian 55 strategist Abhijit Chakrabortti 55 analyst Vivek Juneja 55 Kenji Masuzoe 55 analyst Amit Hazan 55 Charles Boorady 55 Kevin Scotcher 55 Vivek Arya 55 Pulte Homes Presentation 55 Rohini Pragasam spokeswoman 55 Andreas Theisen 55 UBS AG UBS UBSN.VX 55 analyst Robert Cihra 55 Nick Bertolotti 55 Maintains Overweight 55 Robert Koort 55 Reiterates Buy Rating 55 Sam Fazeli 55 Reiterates Sell 55 analyst Albert Savastano 55 About DonHarrold.net DonHarrold.net 55 Alain Karaoglan 55 analyst Srini Pajjuri 55 Nigel Dally 55 Pranjul Bhandari 55 analyst Patrick Pinschmidt 55 Valentin Marinov 55 Johanna Chua 55 analyst Jami Rubin 55 Enam Securities Pvt 55 Tom Cholnoky 55 Glenn Reicin 55 analyst Betsy Graseck 55 Mark Monane 55 Zekauskas 55 analyst Ikuo Matsuhashi 55 economist Takuji Aida 55 Ms. Lewent 55 Ken Hoexter 55 analyst Amir Rozwadowski 55 ThinkEquity downgraded 55 Maintains Neutral 55 analyst Vijay Jayant 55 economist Ryo Hino 55 analyst Doug Anmuth 55 spokeswoman Tatjana Domke 55 Financial XLF Bearish 55 Orbimed 55 Piper Jaffray downgraded 55 Kathryn Huberty 55 Julian Callow economist 55 Analyst Bill Pecoriello 55 CIBC Oppenheimer 55 analyst Maynard Um 55 Creditsights 54 Tony Clapsis 54 Citigoup 54 analyst Tony Shiret 54 economist Huang Yiping 54 recommends overweighting 54 Jonathan Ruykhaver 54 economist Sunil Kapadia 54 Rachael Rothman 54 Ken Zerbe 54 Mintz Levin Represents 54 Olav Zilian 54 UBS Initiates Coverage 54 analyst Liana Moussatos 54 IVGN 54 Christopher LaFemina 54 Nasdaq IDIX 54 Consumer Discretionary XLY Bearish 54 Regeneron Pharma 54 Denhoy 54 analyst Laurent Horrut 54 Mark Ebbinghaus 54 strategist Mahesh Swaminathan 54 analyst Sanjay Vidyarthi 54 economist Naoki Murakami 54 Reiterates Buy rating 54 Rollover Options Bob 54 Analyst Andrew Zarnett 54 firmā 54 Markus Diethelm 54 Eva Quiroga 54 Ralph Giacobbe 54 Industrial XLI Bearish 54 analyst Mark Lipacis 54 Bayer BAY.ETR 54 please visit www.ml.com 54 bln Sfr 54 Rebecca Runkle 54 Rating Reiterated 54 Vishal Shreedhar 54 analyst Geoffrey Porges 54 Stanicky 54 Lowers PT 54 Cory Kasimov 54 analyst Pablo Zuanic 54 spokeswoman Sachiko Hasegawa 54 BoA Merrill Lynch 54 Pantginis 54 economist Elga Bartsch 54 Barclays Capital Reiterate Overweight 54 spokeswoman Tatiana Togni 54 Romit Shah 54 Andy Kaplowitz 54 Energy XLE Bearish 54 Christopher Danely 54 strategist Satoru Ogasawara 54 Leonard Teitelbaum 54 Hussein Allidina 54 EPT Disclosure 54 Doug Sipkin 54 IG FSV ;) CO 54 Estimates Boosted 54 economist Akira Maekawa 54 Neutral Weight 54 analyst Shebly Seyrafi 54 IG HCR ;) CO 54 Chris Danely 54 analyst Mario Mendonca 53 Kaumil Gajrawala 53 Thomas Cholnoky 53 analyst Robert Drbul 53 Broker Roundup 53 analyst Rob Rutschow 53 Orbimed Advisors LLC 53 FBR Capital Upgrades 53 Mark Wienkes 53 CE Unterberg 53 Ladenburg Thalmann Bove 53 Randal Konik 53 Daniele Antonucci 53 Lawrence Biegelsen 53 BoAML 53 analyst Michael Masdea 53 RESEARCH ALERT UBS 53 Nilesh Jasani 53 Andrew Goodsall 53 Makoto Yamashita strategist 53 Rupak Ghose 53 Wells Fargo Initiates Coverage 53 Christopher Horvers 53 reinitiated coverage 53 analyst Shinya Yamada 53 PDL BioPharma PDLI 53 Lawrence Keusch 53 analyst Tasneem Azim 53 analyst Justin Yagerman 53 Carl Christensen XPRESSTRADE 53 analyst Simona Jankowski 53 analyst Stephen Tusa 53 Bret Holley 53 Aaron Reames 53 marketperform 53 AGâ 53 Nik Modi 53 Maintains Outperform 53 Andrew Vaino 53 Peter Rozenberg 53 ThinkEquity Partners LLC 53 Andrew Obin 53 Group Inc JEF.N 53 Inc. NASDAQ EVVV 53 Phil Nalbone 53 analyst Charles Boorady 53 Forest Labs FRX 53 Varian Semi 53 Satoru Ogasawara strategist 53 Karen Boodram 53 Citi Initiates Coverage 53 analyst Dan Wantrobski 53 Joseph Evangelisti spokesman 53 Ajit Pai 53 analyst Kota Yuzawa 53 DSP Merril Lynch 53 Healthcare Conf 53 Heather Bellini 53 economist Yelena Shulyatyeva 53 Philip Alling 53 analyst Koya Tabata 53 analyst Joanne Wuensch 53 analyst Thilo Wrede 53 analyst Amrita Sen 53 analyst Mitul Kotecha 53 Kevin Ellich 53 analyst Jeff Fidacaro 53 Christine Farkas 53 GILD GILD 53 analyst Kirk Materne 53 Jim Bantis 53 RESEARCH ALERT Goldman 53 Hovnanian Enterprises Presentation 53 Beazer Homes Presentation 53 Conviction Sell 53 analyst Philippe Houchois 53 Lori Appelbaum 53 BioRexis 53 Stefan Graber 53 Piper Jaffray PJC 53 analyst Tim Klasell 53 Marc Irizarry 53 Wedbush Maintains 53 Maintains Hold 53 J.P. Morgan 53 BioMarin Pharma 53 economist Chetan Ahya 53 Leerink 53 Tom Nides 53 BAS ML 53 Daniel Meron 53 Timna Tanners 53 analyst Andrey Glukhov 52 economist Marisa Fassler 52 analyst Darin Arita 52 Istvan Zsoldos 52 Manishi Raychaudhuri 52 spokesman Michael Hanretta 52 economist Kwon Goohoon 52 Ben Reitzes 52 Switzerlandâ 52 Drew Matus economist 52 RESEARCH ALERT Lehman 52 Inc JEF JEF 52 Dahlman Rose downgraded 52 analyst Thorsten Wenzel 52 Jay Vleeschhouwer 52 John Kartsonas 52 Stephen Tusa 52 Piper Jaffray Upgrades 52 Fixed Income Strategist 52 analyst Randy Binner 52 Larry Biegelsen 52 Patrice Milos 52 Alnylam Nasdaq ALNY 52 Michael Bruynesteyn 52 strategist Brian Belski 52 John F. Thero 52 Andrea Rachman 52 Vincent Mutel CEO 52 Justin Perras 52 Bob Drbul 52 John Herrlin 52 Mingchun Sun 52 Aldo Mazzaferro 52 Maintains Buy 52 RESEARCH ALERT 52 Chief Equity Strategist 52 Steven Vames 52 Xenoport Inc. 52 economist Hiroshi Shiraishi 52 Lazard Hires 52 Kirsten Drejer 52 Prashant Bhatia 52 Initiate Coverage 52 Peer Perform rating 52 Brent Thill 52 Dan Heyler 52 Thoratec Presentation 52 Co. MER 52 April Scee 52 Monane 52 Julian Heslop 52 Analyst Ben Reitzes 52 Candace Browning 52 Samuel Waksal pleaded guilty 52 Suneet Kamath 52 JMP Securities JMP 52 Dale Pfost 52 Liana Moussatos 52 Ehud Gelblum 52 Drew Fromkin President 52 Sherri Scribner 52 Cormac Leech 52 economist Stephane Deo 52 FBR Capital Maintains 52 Kochnover 52 Nasdaq IPXL 52 Broadpoint Gleacher 52 analyst Philippe Huchois 52 Punk Ziegel 52 Michael Shillaker 52 analyst Frank Mitsch 52 Tanona 52 Betsy Graseck 52 Geoff Porges 52 Jefferies Quarterdeck division 52 deutsche bank 52 Luuk van Beek 52 Helvea AG 52 Kian Abouhossein 52 http:/www.bearstearns.com 52 Piper Jaffray Initiates Coverage 52 Roland Haefeli 52 Piper Jaffray Downgrades 52 analyst Margaret Mager 52 equalweight rating 52 Dennis Weatherstone 52 Moszkowski wrote 52 Elga Bartsch 52 analyst Mark Liinamaa 52 Eric Wasserstrom 52 Dominic Valder 52 Arnaud Langlois 52 Amylin Eli Lilly 52 Manuel Oliveri 52 analyst Michael Bruynesteyn 52 Manoj Singla 52 Michael Rehaut 52 Maintains Hold Rating 52 Meredith Adler 52 analyst Kimberly Greenberger 52 Finncap 52 NeoGenesis 52 Tony Lesiak 52 Matt Miksic 52 analyst Michael Slifirski 52 Marisa Fassler 52 Edward Ditmire analyst 52 Michael Vinciquerra 52 Entropin 52 Trevor Polischuk 52 analyst Gregory Melich 52 Justin Hott 52 analyst Mark Monane 52 analyst Sal Tharani 51 Helvea SA 51 WR Hambrecht reiterate 51 Sol Barer 51 Darren Lehrich 51 analyst Jay Defibaugh 51 Cannacord Genuity 51 analyst Brad Reback 51 MOVES Deutsche 51 Uche Orji 51 Charles Stanley stockbrockers 51 Valeant Pharma 51 Tobias Merath head 51 Raghu Hariharan 51 analyst Cusson Leung 51 Biomarin 51 Shari Schwartzman Eberts 51 Simos Simeonidis 51 Kulbinder Garcha 51 Inc. Endures Analyst 51 Lexicon Pharmaceuticals 51 Jefferies JEF 51 Michael Bilerman 51 Robyn Karnauskas 51 analyst Robyn Karnauskas 51 www.bearstearns.com 51 ANALYST TAKE Citi 51 Jonathan Chenevix Trench 51 TPG Bain Capital 51 Member CIPF 51 John Carrafiell 51 Arjan van Veen 51 Tony Shiret analyst 51 analyst Jason Gurda 51 Isis Pharma 51 analyst Maarten Altena 51 Maintains Neutral Rating 51 Scott Geels 51 marketweight 51 Aneta Markowska 51 analyst Phillip Nalbone 51 Estimates Lowered 51 OPERATOR Next 51 eResearch sole 51 JP Morgan 51 William F. Tanona 51 JJ Traynor 51 Keay Nakae 51 4Q Profit Beats Expectations 51 gs-investor-relations@gs.com 51 Georges Gemayel 51 analyst Rajiv Setia 51 Weisel Partners 51 Genelabs Technologies 51 PaineWebber Incorporated 51 Daljeet Kohli head 51 Morgan Stanley 51 UBS Warburg LLC 51 analyst Donald Fandetti 51 Abhijit Chakrabortti 51 Bhavin Shah 51 analyst Vishal Shreedhar 51 ADR depositary 51 Barclays Maintains 51 Reiterates Buy 51 Raises PT 51 analyst Victor Bareno 51 George Toriola 51 Ariad Pharmaceuticals 51 Jeffrey Holford 51 Valeant Pharmaceuticals NYSE VRX 51 Maintains Sell 51 Jon Diat spokesman 51 BofA ML 51 Drickamer 51 economist Anton Gunawan 51 Francois Trahan 51 Tsukasa Noda 51 NYSE GIZ 51 Stacy Rasgon 51 Pablo Zuanic 51 Catalyst Biosciences 51 Ed Canaday 51 analyst Sterling Auty 51 analyst Jefferson Harralson 51 analyst Per Lekander 51 analyst Dinesh Moorjani 51 Auriga USA 51 analyst Glyn Lawcock 51 Q2 adj 51 economist Drew Matus 51 Jim Reddoch 51 Nick Spoliar 51 Biogen Nasdaq BIIB 51 Amelia Bourdeau 51 DiMaio Ahmad 51 Eric Varvel 51 Nasdaq NPSP 51 Lazard LAZ.N Quote Profile 51 spokeswoman Rohini Pragasam 51 analyst Junaid Husain 51 Dr. LaMattina 51 t2cure GmbH 51 RDQ Economics wrote 51 Sven Jari Stehn 51 RESEARCH ALERT Morgan Stanley 51 SUBPRIME TODAY 51 Equal Weight rating 51 Geoffrey Porges 51 http:/www.ibb.ubs.com 51 Steinerman 51 Quynh Pham 51 Riccardo Trecroce 51 analyst Glenn Schorr 51 analyst Glenn Reicin 51 BGB Securities 51 Frank Quattrone Qatalyst Partners 51 Oscar Gruss 51 Staphos 51 Rick Bensignor 51 NASDAQ NOVN today 51 Trend Macrolytics LLC 51 Wedbush Morgan downgrades 51 Knight Libertas LLC 51 analyst Hideyuki Maekawa 51 Dylan Cathers 51 analyst Sven Kreitmair 51 Sagent Advisors 51 RESEARCH ALERT Credit Suisse 51 Nicholas Galakatos 51 Susumu Kato 51 Darrell Duffie 51 Elga Bartsch economist 51 analyst Ken Hoexter 51 JoAnne Feeney 51 Combinatorics Capital 51 Katy Huberty 51 Deborah L. Weinswig 51 J. Steven Smigie 51 Broadpoint DESCAP 51 Endures Analyst Downgrade 51 Faisel Khan 51 Daniel Junius 51 Houchois 50 Abhey Lamba wrote 50 David Amsellem 50 Jeff Omohundro 50 Ulrich Huwald 50 Range Tightening 50 Unterberg Towbin 50 RESEARCH ALERT JP Morgan 50 analyst Frederick Searby 50 analyst Irene Himona 50 LODH 50 Ton van Ooijen 50 Suki Cooper analyst 50 Sipkin 50 Jonathan Aschoff 50 analyst Rommel Dionisio 50 Wiktor Bielski 50 spokesman Kris Kagel 50 analyst Jeff Kvaal 50 Kuni Chen 50 Curt Woodworth 50 Blair Effron 50 Geraud Charpin 50 Willem Sels 50 analyst Kathryn Huberty 50 Hodes Weill 50 Bert Hazlett 50 Adrianne Shapira 50 Alnylam Pharma 50 Hiroshi Shiraishi economist 50 JMP Securities downgraded 50 analyst Hisashi Moriyama 50 Amir Rozwadowski 50 economist Rohini Malkani 50 analyst Manuel Oliveri 50 Q3 Adj 50 Sveinn Palsson 50 Peter Redward 50 Hannes Wittig 50 economist Masaaki Kanno 50 Kaufman Bros 50 Chris Umiastowski 50 Treasurer Paolo Tonucci 50 A. Reitzes 50 analyst Nikos Theodosopoulos 50 Morgan Stanley NYSE BDJ 50 analyst PJ Juvekar 50 Morgan Joseph TriArtisan 50 economist Ken Wattret 50 Savita Subramanian 50 analyst Geoffrey Yu 50 Adam Barkstrom 50 Ben Uglow 50 Kevin Buchi 50 reinitiates 50 analyst Ross Muken 50 analyst Connie Maneaty 50 Oswald Grubel 50 analyst Yuji Fujimori 50 Thomas R. Wadewitz 50 James SJ Manuso 50 BlackRock Fink 50 Jack Malvey 50 Erich Hunziker 50 Okumus Capital 50 Roger Noall 50 analyst Allan Mishan 50 ABN AMRO Incorporated 50 economist Tetsufumi Yamakawa 50 analyst Raj Denhoy 50 Sam Buttrick 50 Cyclacel Pharmaceuticals 50 Michel Peretie 50 analyst Mahesh Sanganeria 50 Piper Jaffray Reiterates 50 B. Nemeroff 50 Rajesh Ghai 50 Analyst Joseph Greff 50 Jed Dorsheimer 50 Rigel Pharmaceuticals 50 AG DB DBK.XE 50 Elazar Rabbani 50 Edward Najarian 50 THE RATINGS GAME 50 Kathleen Bostjancic 50 CAI Cheuvreux 50 Merrill lynch 50 Elkan Scheidt 50 Nextech Venture 50 Daniel Kerven 50 LifeTech Capital 50 MS NASDAQ MNDX 50 Bristol Myers BMY 50 Sumit Malhotra 50 Tahira Afzal 50 Alan Webborn 50 analyst Ananda Baruah 50 Navdeep Jaikaria 50 Ronny Gal 50 Kris Kagel 50 UBS 50 Reiterates Strong 50 analyst Katherine Styponias 50 Michael Hanretta declined 50 Keshav Sanghi 50 Piper Jaffray Maintains 50 Larry Hatheway 50 Analyst Richard Withagen 50 analyst Tien tsin 50 analyst Edward Ditmire 50 Drew Matus 50 Equinet Institutional Services 50 Anton Wahlman 50 Claudia Shank 50 nyse MWD news 50 1Q Profit Beats 50 analyst Ingrid Sternby 50 Moussatos 50 Jay Deahna 50 analyst Benjamin Reitzes 50 Jeff Kvaal 50 Q2 Adj 50 Randy Binner 50 Ardour Capital 50 Garo Toomajanian 50 Analysts Reiterate Neutral Rating 50 Myriad Genetics Inc 50 Sergey Vasnetsov 50 John R. Plachetka 50 Takehiro Sato economist 50 MOGN 50 Herbert McDade 50 Kota Yuzawa 50 Jon LeCroy 50 Joshua Shanker 50 Saftlas 50 economist Rob Subbaraman 50 3Q Profit Doubles 50 Neil Flanzraich 50 Bain Capital KKR 50 ANALYST TAKE Credit Suisse 50 Jay Gelb 50 S. Drbul 50 Gilead Sciences NASDAQ GILD 50 Jefferies Broadview 50 Daniel Vasella Chairman 50 Dhruv Chopra 50 analyst Konrad Becker 50 George Staphos 50 Anurag Rana 50 William Plovanic 50 JMP Securities downgrade 50 Lukas Muehlemann 50 Anindya Mohinta 50 Piper Jaffray reiterates 50 www.lazard.com 50 Sara Elford 50 Maintains outperform 50 Nollenberger Capital 50 Shai Gozani 50 Jean Philippe Bertschy 50 Rod Bourgeois 50 CorporateCommunications +#-#-#-# 50 Matt Spick 50 STREET MOVES Morgan Stanley 50 Axcan Pharma 50 Piper Jaffray reiterate 50 Bernard Hanssens 50 #/#/#-Citigroup 50 Claude Camire 50 Inc CYBX 50 James Manuso 50 BioCentury NewsMakers 50 Joe Nadol 50 analyst Sasa Zorovic 50 reinitiates coverage 50 Randy Whitestone 50 Seattle Genetics SGEN 50 MS NYSE MWJ 50 ThankYou Prestige card 50 John Segrich 50 Tibco TIBX 50 CardioVascular BioTherapeutics 50 analyst Constance Maneaty 50 Michael Jalonen 50 analyst Guy Moszkowski 50 analyst Douglas Sipkin 50 Nessuah Zannex 50 Justin Yagerman 50 Psivida 50 Edward Tenthoff 50 Christopher Blansett 50 SAP SAP.ETR 50 alum Vikram Pandit 50 Dan Passeri 50 Thomas Nagtegaal 50 QLT QLTI 50 Qatalyst Group 50 Michael Duvally 50 Edgar Roesch 50 Anand Ramachandran 50 Joseph Osha 50 Michael Turits 50 Sophia Drossos 50 Ahmar Zaman 50 analyst Alvin Kwock 50 lowers FY# EPS 50 analyst Takaki Nakanishi 50 Maintains Outperform Rating 50 Paul Laikind 50 Thomas Nides 50 economist Kyohei Morita 50 Barrie Cornes analyst 50 Keeps Outperform 50 analyst Patrick Walravens 50 Group CS CSGN.VX 50 Hamid Biglari 50 Glenn Novarro 50 Evgeny Solovyov 50 FBR Capital Reiterates 49 Andrew Garthwaite 49 Darren Aftahi 49 Lars Kjellberg 49 Securities Ld EPT 49 analyst Aryeh Bourkoff 49 Rhein Biotech GmbH 49 RESEARCH ALERT Prudential 49 P. Appert 49 Joe Giamichael 49 Fereydoun Firouz 49 Christian Homsy 49 Claudio Costamagna 49 Deutsche Bk 49 analyst Jorge Beristain 49 Allan Monks 49 ThinkPanmure LLC 49 analyst Andrew Obin 49 CSFB Upgrades 49 Navigant Consulting Inc 49 Laurent Fransolet 49 spokeswoman Kristin Lemkau 49 Auxilium Pharma 49 Submits Response 49 Aktiengesellschaft DB #/#/# PriceWatch 49 PDGI 49 analyst Ghansham Panjabi 49 CEO Tod Woolf 49 Broker Investec 49 Mark Liinamaa 49 Sonal Varma economist 49 Sylvie Gregoire 49 Ananda Baruah 49 Schoenebaum 49 Michael Cembalest 49 Helvea 49 Banca Imi 49 Goldmann Sachs 49 Lazard LAZ.N 49 ING BHF Bank 49 Seshadri Sen 49 Lee Fensterstock Chairman 49 Schwab SoundView 49 NASDAQ SLXP 49 Health Innoventures 49 NYSE PJC 49 Nasdaq AVNR 49 Eric Coldwell 49 Holding TWSE 49 Daniel Fannon 49 Alkesh Shah 49 Mahesh Swaminathan 49 HealthCor 49 Cannacord Adams 49 Lutz Giebel 49 Underweight rating 49 Emkay Research 49 Ton Gietman 49 ACADIA Pharmaceuticals 49 Montevirgen 49 Westrock Advisors 49 analyst Heather Bellini 49 Jon Bergtheil 49 Robert Drbul 49 Lauren Cooks Levitan 49 Kasumovich 49 Raises Estimates 49 Joshua Schimmer 49 MER.N 49 Inc. Nasdaq AFFY 49 Sunesis Pharmaceuticals 49 Sirona Dental 49 analyst Angie Sedita 49 Alessandro Migliorini 49 TNGN 49 Nasdaq IDRA today 49 AG CSGN.VX 49 analyst Raghu Hariharan 49 Anthony J. Armini 49 Daniel Berenbaum 49 Kenneth Moelis 49 Mahesh Sanganeria 49 CIMA LABS 49 SGXP 49 Ben Mogil 49 analyst Peter Ruschmeier 49 Tomas Lajous 49 Ladenburg Thalmann analyst 49 Lisa Krinsky 49 Glenn Schorr 49 Sanjay Vidyarthi 49 analyst Simos Simeonidis 49 A. Leerink 49 Lexicon Partners 49 Michael Rietbrock 49 RBC Capital NYSE RY 49 Rhyee 49 Simeonidis 49 marketperformer 49 Comfort #-#-# ccomfort@dresources.com 49 analyst Stuart Plesser 49 Barclays Reiterates 49 Michael DuVally 49 economist Julian Callow 49 Amex KAL 49 analyst Mark Wiltamuth 49 PiperJaffray analyst 49 Robin Bhar metals 49 brokerage Helvea 49 analyst Ajit Pai 49 Rampertab 49 NEUTRAL rating 49 Ixis Securities 49 Lazard LAZ 49 spokeswoman Renee Calabro 49 Cambria Biosciences 49 Bullish Engulfing Formed 49 HSBC Pantelakis Securities 49 Brigantine Advisors 49 Maintains Market Perform 49 Mike Krensavage 49 Pat Walravens 49 analyst Joseph Greff 49 Emkay Global 49 rue# inc 49 Mindray Medical 49 spokesman Bill Halldin 49 NYSE RNE 49 Healthcare CEOs Unscripted 49 analyst Katy Huberty 49 Tobias Levkovich 49 Brean Murray reiterate 49 ZIOPHARM Oncology 49 analyst Arnab Chanda 49 analyst Walter Piecyk 49 PhD RPh 49 Brian Gesuale